Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type I cuticular Ha3-I (KRT33A) is a member of the keratin gene family and encodes a type I (acidic) hair keratin protein[1]. It is primarily expressed in hair and nails, where it heterodimerizes with type II keratins to form structural intermediate filaments critical for the formation and mechanical properties of hair and nail[1]. This gene is clustered with other type I hair keratin genes on human chromosome 17q21.2 and is distinct from its closely related isoform, KRT33B, by being encoded by a separate gene[1]. The main biological role of KRT33A is its contribution to the structural integrity of hair fibers; no evidence currently exists for its direct role as a therapeutic target, disease biomarker, or drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cuticular Ha3-I (KRT33A).